Marksans Pharma shareholders and shareholding pattern
NSE: MARKSANSBSE: 524404Pharmaceuticals & BiotechnologySmall Cap
Formerly Tasc Pharmaceuticals
Last close ₹286.90down ₹7.55 (2.56%)BSE ₹286.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹294.45.
52-week range of traded prices to 23 Oct 2026
₹155.00Low, 30 Mar 2026₹350.95High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹13,001 Cr592nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 25.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 4.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 12 Aug 2026
- 17.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 14,14,61953.0% delivered
Who owns Marksans Pharma, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters43.87%
- Foreign institutions19.06%
- Indian institutions5.54%
- Individuals and others31.53%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 12 Jan | Mar 2017Filed 18 Apr | Jun 2017Filed 20 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 19 Jan | Mar 2018Filed 17 Apr | Jun 2018Filed 17 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 16 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 18 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 17 Jul | Sep 2020Filed 14 Oct | Dec 2020Filed 13 Jan | Mar 2021Filed 14 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 13 Oct | Dec 2021Filed 17 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 19 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 12 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 17 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 11 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 10 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.60% | 49.00% | 43.85% | 43.85% | 43.85% | 43.85% | 43.85% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | |
| Indian promoters | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.25% | 48.60% | 49.00% | 43.85% | 43.85% | 43.85% | 43.85% | 43.85% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.75% | 51.40% | 51.00% | 56.15% | 56.15% | 56.15% | 56.15% | 56.15% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% | 56.13% |
| Shares in issue | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,93,13,698 | 40,63,57,365 | 40,30,34,114 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 | 45,31,63,746 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | – | – | – | – | – | – | – | – | 1,000 | – | – | – | – | – | – | 19,74,91,553 | 19,74,91,553 | 19,74,91,553 | 0 | 0 | 0 | 0 | 5,03,24,324 | 5,03,24,324 | 5,03,24,324 | 5,03,24,324 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | – | – | – |
| Promoters' shares locked in | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 19,74,91,553 | 19,74,91,553 | 19,74,91,553 | 0 | 0 | 0 | 0 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Marksans Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is MARK SALDANHA, 43.80%.Promoter buying and selling
| Holder | ||
|---|---|---|
| MARK SALDANHAIndividuals and Hindu undivided families | 43.80% | 19,84,91,553 |
| Schenelle Megan SaldanhaIndividuals and Hindu undivided families | 0.03% | 1,45,000 |
| SANDRA SALDANHAIndividuals and Hindu undivided families | 0.02% | 1,02,183 |
| Merrill Jean SaldanhaIndividuals and Hindu undivided families | 0.01% | 63,273 |
| Marise Ann SaldanhaIndividuals and Hindu undivided families | 0.00% | 20,000 |
No promoter shares are reported as pledged.
Largest public holders of Marksans Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Marksans Pharma
| Holder | Dec 2016Filed 12 Jan | Mar 2017Filed 18 Apr | Jun 2017Filed 20 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 19 Jan | Mar 2018Filed 17 Apr | Jun 2018Filed 17 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 16 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 18 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 17 Jul | Sep 2020Filed 14 Oct | Dec 2020Filed 13 Jan | Mar 2021Filed 14 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 13 Oct | Dec 2021Filed 17 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 19 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 12 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 17 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 11 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 10 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORBIMED ASIA IV MAURITIUS FVCI LIMITEDForeign direct investment | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.88% | 10.88% | 10.88% | 10.88% | 10.88% | 10.88% | 10.88% | 10.88% | 10.88% | 8.62% | 8.62% | 8.62% | 8.62% | 8.62% | 8.62% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGYForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.32% | 2.32% | 2.32% | 2.32% | 2.32% | – | – | – | – | – |
| MUKUL MAHAVIR AGRAWALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.22% | 1.22% | 1.22% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MUKUL MAHAVIR PRASAD AGRAWALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | 1.03% | 1.59% | 1.71% | 1.86% | 1.86% | 1.86% | 1.88% | 1.95% | 1.95% | 1.95% | 1.95% | 1.95% | 1.47% | 1.47% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ASHISH KACHOLIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.25% | 1.25% | 1.25% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MONDRIAN EMERGING MARKET SMALL CAP EQUITY FUND, L.P.Other Institutions | 2.68% | – | – | 1.64% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ONTARIO PENSION BOARDS- MONDRIAN INVESTMENT PARTNERS LIMITEDInstitutions Foreign Portfolio Investor | – | – | – | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MONDRIAN EMERGING MARKET SMALL CAP EQUITY FUNDOther Institutions | – | 2.48% | 2.29% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ONTARIO PENSION BOARD - MONDRIAN INVESTMENT PARTNER LIMITEDInstitutions Foreign Portfolio Investor | 1.15% | 1.15% | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| WASATCH EMERGING MARKETS SMALL CAP FUNDInstitutions Foreign Portfolio Investor | 1.52% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CALIFORNIA PUBLIC EMPLOYEES' RETIREMENT SYSTEM, MANAGED BY WASATCH ADVISORS, INC.Institutions Foreign Portfolio Investor | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.